Dissertanten

Wir gratulieren!

    2016

  • Hutterer Evelyn

    Paris-Lodron Universität Salzburg

    The interplay of DNA methylation, trisomy 12 and integrin regulation in the pathophysiology of chronic lymphocytic leukemia

  • 2016

  • Krenn Peter

    Paris-Lodron Universität Salzburg

    Contribution of cytoskeleton regulating molecules to chronic lymphocytic cell survival and proliferation

  • 2016

  • Sifft Eveline

    Paris-Lodron Universität Salzburg

    Antiapoptotic function of p21 regarding its subcellular localization in As203 induced apoptosis in CLL

  • 2016

  • Ganghammer Sylvia

    Paris-Lodron Universität Salzburg

    Regulation of chemokine-mediated VLA-4-activation in chronic lymphocytic leukemia

  • 2015

  • Rebhandel Stefan

    Paris-Lodron Universität Salzburg

    DNA deamination in chronic lymphocytic leukemia (CLL), AID and APOBEC3 as sources of genomic damage

  • 2015

  • Huemer Michael

    Paris-Lodron Universität Salzburg

    The significance of the activation-induced cytidine deaminase in the clonal evolution of chronic lymphocytic leukemia and its abundance, localization and activity

  • 2015

  • Hufnagl Clemens

    Paris-Lodron Universität Salzburg

    Evaluation of circulating cell free DNA as a molecular monitoring tool during cancer therapy

  • 2014

  • Grössinger Eva

    Paris-Lodron-Universität Salzburg

    The role of ion channels in CLL

  • 2013

  • Kocher Thomas

    Paracelsus Medizinische Privatuniversität Salzburg

    Immune Interactions in Chronic Lymphocytic Leukemia

  • 2013

  • Girbl Tamara

    Paris-Lodron-Universität Salzburg

    The microenvironmental regulation of adhesion and migration in chronic lymphocytic leukemia

  • 2012

  • Brachtl Gabriele

    Paris-Lodron Universität Salzburg

    The involvement of CD38 and VLA-4 in migration, survival and proliferation of B chronic lymphocytic leukemia cells

  • 2012

  • Gassner Franz

    Paris-Lodron Universität Salzburg

    T cells in chronic lymphocytic leukaemia display an exhausted phenotype and impaired functionality that can be restored by chemotherapy.

  • 2012

  • Weiss Lukas

    Paracelsus Medizinische Privatuniversität Salzburg

    The duality of t-cells in chronic lymphocytic leukemia.

  • 2010

  • Wacht Nathalie

    Paris-Lodron Universität Salzburg

    Novel substances for high risk CLL patients „CLL1“ – a promising option.

  • 2010

  • Asslaber Daniela

    Paris-Lodron Universität Salzburg

    MicroRNAs in the Pathology of B-Cell Chronic Lymphocytic Leukemia.

  • 2010

  • Olivier Angelika

    Leopold-Franzens Universität Innsbruck

    The Chemokine Network: CCL27/ CTACK in Multiple Myeloma and Implications in Immune Cell Function.

  • 2010

  • Maizner Eva

    Leopold-Franzens Universität Innsbruck

    Expression profiles of PKB/AKT isoforms in multiple myeloma.

  • 2009

  • Hofbauer Sebastian

    Paris-Lodron Universität Salzburg

    The Role of Protein Kinase B and Tcl1a in the Survival of B – Chronic Lymphocytic Leukemia Cells.

  • 2009

  • Desch Petra

    Paris-Lodron Universität Salzburg

    Cancer Stem Cells and Self-Renewal Pathways in B-Cell Chronic Lymphocytic Leukemia.

  • 2008

  • Gryshchenko Irina

    Paracelsus Medizinische Privatuniversität Salzburg

    Rolle des SNP309 im Promotor von MDM2 und p53 Status bei chronisch lymphatische Leukämie (B-CLL).

  • 2008

  • Holler Claudia

    Paris-Lodron Universität Salzburg

    The Role of T cell receptor and B cell receptor characteristics in B cell chronic lymphocytic leukaemia (CLL).

  • 2008

  • Melchardt Thomas

    Paracelsus Medizinische Privatuniversität Salzburg

    New Drugs for high risk B-CLL patients: Screening of plant and microbe derived compounds.

  • 2004

  • Anether Gabriele

    Leopold-Franzens Universität Innsbruck

    Apoptotische und antiapoptotische Signale und deren medikamentösen Beeinflussung der B-Zell chronisch lymphatischen Leukämie.